[Question] Spain — has anyone got a straight answer on MHRA
The title is the whole question — Spain — has anyone got a straight answer on MHRA — but here is why I am asking.
Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.
Scotland, Wales and Northern Ireland have their own arrangements. An answer that begins with "in England" should say so, and most of the confusion here comes from answers that do not.
Pharmacy pricing on a private prescription is set by the pharmacy. The spread between them in a given month is routinely substantial, which is why a tracker built from member reports is more useful than any headline.
Corrections welcome, especially the pedantic ones. Pedantry is how this board earns its reputation.
best — the order this archive was captured in
A private prescription is an independent route: it does not affect NHS list position, and it is not a step in the same pathway.
Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.
no referral links, ever, and that rule is why the pricing threads work
Left up. It names a nation and an ICB, which is all we ask of a pathway post.
Left up.
Adding the practical bit — ask what happens at discharge before you start, not after.
Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.